BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 16082197)

  • 1. p53 proteasomal degradation: poly-ubiquitination is not the whole story.
    Asher G; Shaul Y
    Cell Cycle; 2005 Aug; 4(8):1015-8. PubMed ID: 16082197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ubiquitin-independent degradation: lessons from the p53 model.
    Asher G; Shaul Y
    Isr Med Assoc J; 2006 Apr; 8(4):229-32. PubMed ID: 16671355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A mechanism of ubiquitin-independent proteasomal degradation of the tumor suppressors p53 and p73.
    Asher G; Tsvetkov P; Kahana C; Shaul Y
    Genes Dev; 2005 Feb; 19(3):316-21. PubMed ID: 15687255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NRH:quinone oxidoreductase 2 and NAD(P)H:quinone oxidoreductase 1 protect tumor suppressor p53 against 20s proteasomal degradation leading to stabilization and activation of p53.
    Gong X; Kole L; Iskander K; Jaiswal AK
    Cancer Res; 2007 Jun; 67(11):5380-8. PubMed ID: 17545619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. P53 hot-spot mutants are resistant to ubiquitin-independent degradation by increased binding to NAD(P)H:quinone oxidoreductase 1.
    Asher G; Lotem J; Tsvetkov P; Reiss V; Sachs L; Shaul Y
    Proc Natl Acad Sci U S A; 2003 Dec; 100(25):15065-70. PubMed ID: 14634213
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mdm-2 and ubiquitin-independent p53 proteasomal degradation regulated by NQO1.
    Asher G; Lotem J; Sachs L; Kahana C; Shaul Y
    Proc Natl Acad Sci U S A; 2002 Oct; 99(20):13125-30. PubMed ID: 12232053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 20S proteasomal degradation of ornithine decarboxylase is regulated by NQO1.
    Asher G; Bercovich Z; Tsvetkov P; Shaul Y; Kahana C
    Mol Cell; 2005 Mar; 17(5):645-55. PubMed ID: 15749015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ubiquitin-independent p53 proteasomal degradation.
    Tsvetkov P; Reuven N; Shaul Y
    Cell Death Differ; 2010 Jan; 17(1):103-8. PubMed ID: 19557012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 20S proteasomes and protein degradation "by default".
    Asher G; Reuven N; Shaul Y
    Bioessays; 2006 Aug; 28(8):844-9. PubMed ID: 16927316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p53 Ubiquitination and proteasomal degradation.
    Love IM; Shi D; Grossman SR
    Methods Mol Biol; 2013; 962():63-73. PubMed ID: 23150437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ell3 stabilizes p53 following CDDP treatment via its effects on ubiquitin-dependent and -independent proteasomal degradation pathways in breast cancer cells.
    Ahn HJ; Kim KS; Shin KW; Lim KH; Kim JO; Lee JY; Kim J; Park JH; Yang KM; Baek KH; Ko JJ; Park KS
    Oncotarget; 2015 Dec; 6(42):44523-37. PubMed ID: 26540344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The homeodomain transcription factor Hoxa2 interacts with and promotes the proteasomal degradation of the E3 ubiquitin protein ligase RCHY1.
    Bergiers I; Bridoux L; Nguyen N; Twizere JC; Rezsöhazy R
    PLoS One; 2013; 8(11):e80387. PubMed ID: 24244684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ubiquitination of E3 ligases: self-regulation of the ubiquitin system via proteolytic and non-proteolytic mechanisms.
    de Bie P; Ciechanover A
    Cell Death Differ; 2011 Sep; 18(9):1393-402. PubMed ID: 21372847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A mutually inhibitory feedback loop between the 20S proteasome and its regulator, NQO1.
    Moscovitz O; Tsvetkov P; Hazan N; Michaelevski I; Keisar H; Ben-Nissan G; Shaul Y; Sharon M
    Mol Cell; 2012 Jul; 47(1):76-86. PubMed ID: 22793692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting the ubiquitin-proteasome system to activate wild-type p53 for cancer therapy.
    Allende-Vega N; Saville MK
    Semin Cancer Biol; 2010 Feb; 20(1):29-39. PubMed ID: 19897040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CHIP stabilizes amyloid precursor protein via proteasomal degradation and p53-mediated trans-repression of β-secretase.
    Singh AK; Pati U
    Aging Cell; 2015 Aug; 14(4):595-604. PubMed ID: 25773675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The role of different E3 ubiquitin ligases in regulation of the P53 tumor suppressor protein].
    Daks AA; Melino D; Barlev NA
    Tsitologiia; 2013; 55(10):673-87. PubMed ID: 25509121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Essential Roles of E3 Ubiquitin Ligases in p53 Regulation.
    Sane S; Rezvani K
    Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28218667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The p53 paddy wagon: COP1, Pirh2 and MDM2 are found resisting apoptosis and growth arrest.
    Corcoran CA; Huang Y; Sheikh MS
    Cancer Biol Ther; 2004 Aug; 3(8):721-5. PubMed ID: 15280670
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytoplasmic destruction of p53 by the endoplasmic reticulum-resident ubiquitin ligase 'Synoviolin'.
    Yamasaki S; Yagishita N; Sasaki T; Nakazawa M; Kato Y; Yamadera T; Bae E; Toriyama S; Ikeda R; Zhang L; Fujitani K; Yoo E; Tsuchimochi K; Ohta T; Araya N; Fujita H; Aratani S; Eguchi K; Komiya S; Maruyama I; Higashi N; Sato M; Senoo H; Ochi T; Yokoyama S; Amano T; Kim J; Gay S; Fukamizu A; Nishioka K; Tanaka K; Nakajima T
    EMBO J; 2007 Jan; 26(1):113-22. PubMed ID: 17170702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.